Liothyronine Sodium
Liothyronine Sodium Tablets, USP
Approved
Approval ID
4a8f7bf4-fa8f-4cde-9be2-11d5a4e6f07f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 9, 2014
Manufacturers
FDA
Aidarex Pharmaceuticals LLC
DUNS: 801503249
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Liothyronine Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code33261-964
Application NumberANDA090097
Product Classification
M
Marketing Category
C73584
G
Generic Name
Liothyronine Sodium
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 9, 2014
FDA Product Classification
INGREDIENTS (6)
LIOTHYRONINE SODIUMActive
Quantity: 5 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM
CALCIUM SULFATEInactive
Code: WAT0DDB505
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT